rs45604738

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000744.7(CHRNA4):​c.1160A>G​(p.Glu387Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000175 in 1,609,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E387K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00081 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

CHRNA4
NM_000744.7 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.43

Publications

6 publications found
Variant links:
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
CHRNA4 Gene-Disease associations (from GenCC):
  • autosomal dominant nocturnal frontal lobe epilepsy 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010844737).
BP6
Variant 20-63350251-T-C is Benign according to our data. Variant chr20-63350251-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 205024.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 124 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000744.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA4
NM_000744.7
MANE Select
c.1160A>Gp.Glu387Gly
missense
Exon 5 of 6NP_000735.1P43681-1
CHRNA4
NM_001256573.2
c.632A>Gp.Glu211Gly
missense
Exon 5 of 6NP_001243502.1Q4VAQ3
CHRNA4
NR_046317.2
n.1369A>G
non_coding_transcript_exon
Exon 5 of 6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA4
ENST00000370263.9
TSL:1 MANE Select
c.1160A>Gp.Glu387Gly
missense
Exon 5 of 6ENSP00000359285.4P43681-1
CHRNA4
ENST00000463705.5
TSL:1
n.1808A>G
non_coding_transcript_exon
Exon 4 of 5
CHRNA4
ENST00000467563.3
TSL:1
n.1230A>G
non_coding_transcript_exon
Exon 5 of 6

Frequencies

GnomAD3 genomes
AF:
0.000822
AC:
125
AN:
152044
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00273
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000184
AC:
44
AN:
238800
AF XY:
0.000145
show subpopulations
Gnomad AFR exome
AF:
0.00244
Gnomad AMR exome
AF:
0.000265
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000108
AC:
157
AN:
1457828
Hom.:
0
Cov.:
99
AF XY:
0.000108
AC XY:
78
AN XY:
725088
show subpopulations
African (AFR)
AF:
0.00275
AC:
92
AN:
33442
American (AMR)
AF:
0.000405
AC:
18
AN:
44410
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26016
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39596
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86040
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51622
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000234
AC:
26
AN:
1110780
Other (OTH)
AF:
0.000249
AC:
15
AN:
60160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000815
AC:
124
AN:
152162
Hom.:
0
Cov.:
32
AF XY:
0.000807
AC XY:
60
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.00270
AC:
112
AN:
41522
American (AMR)
AF:
0.000261
AC:
4
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
67978
Other (OTH)
AF:
0.00190
AC:
4
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000107
Hom.:
0
Bravo
AF:
0.000786
ESP6500AA
AF:
0.000913
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000199
AC:
24
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy (1)
-
-
1
CHRNA4-related disorder (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
9.8
DANN
Benign
0.94
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.81
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.49
T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.74
T
MutationAssessor
Benign
1.9
L
PhyloP100
1.4
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.46
N
REVEL
Uncertain
0.32
Sift
Benign
0.21
T
Sift4G
Benign
0.27
T
Polyphen
0.0020
B
Vest4
0.18
MVP
0.86
MPC
0.47
ClinPred
0.020
T
GERP RS
2.1
Varity_R
0.032
gMVP
0.31
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45604738; hg19: chr20-61981603; API